Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2002012501) ANTI-DUAL INTEGRIN ANTIBODIES, COMPOSITIONS, METHODS AND USES
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2002/012501 International Application No.: PCT/US2001/024784
Publication Date: 14.02.2002 International Filing Date: 07.08.2001
Chapter 2 Demand Filed: 07.03.2002
IPC:
C07K 16/28 (2006.01) ,G01N 33/68 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
28
against receptors, cell surface antigens or cell surface determinants
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68
involving proteins, peptides or amino acids
Applicants:
CENTOCOR, INC. [US/US]; 200 Great Valley Parkway Malvern, , PA 19355, US
Inventors:
GILES-KOMAR, Jill; US
HEAVNER, George; US
SNYDER, Linda; US
TRIKHA, Mohit; US
Agent:
JOHNSON, Philip, S. ; One Johnson & Johnson Plaza New Brunswick, NJ 08933, US
Priority Data:
09/920,26701.08.2001US
60/223,36307.08.2000US
Title (EN) ANTI-DUAL INTEGRIN ANTIBODIES, COMPOSITIONS, METHODS AND USES
(FR) ANTICORPS ANTI-INTEGRINES DOUBLES, COMPOSITIONS, PROCEDES ET UTILISATIONS ASSOCIES
Abstract:
(EN) The present invention relates to at least one novel anti-dual integrin antibodies, including isolated nucleic acids that encode at least one anti-dual integrin antibody, dual integrin, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
(FR) L'invention concerne au moins un nouvel anticorps anti-intégrine double, notamment des acides nucléiques isolés codant au moins pour un anticorps dirigé contre une intégrine double; elle concerne également une intégrine double, des vecteurs, cellules hôtes, animaux ou plantes transgéniques, ainsi que des procédés de préparation et d'utilisation de ces anticorps, notamment des compositions thérapeutiques; elle concerne encore des procédés et dispositifs associés.
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
HRP20030088APLP.366211RSP-94/03YUP-94/03MXPA/a/2003/001230KR1020030022369
VN9302ZA2003/01864EP2253646EP1309693JP2004510414VN8340 1-2003-00127
IL154326CN1468307CA2418962EA200300244NZ524146AU2001283167
DK1309693